カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

赤羽ワクチンの世界市場2022：生ワクチン、不活化ワクチン

■ 英語タイトル：Global Akabane Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3739）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3739
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[赤羽ワクチンの世界市場2022：生ワクチン、不活化ワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の赤羽ワクチン市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の赤羽ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

赤羽ワクチン市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・生ワクチン、不活化ワクチン

アプリケーション別セグメントは次のように区分されます。
・牛、水牛、その他

世界の赤羽ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・CAVAC、Green Cross Veterinary Products、KAKETSUKEN、Kyoritsu Seiyaku Corporation、Kyoto Biken Laboratories、Nisseiken

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、赤羽ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な赤羽ワクチンメーカーの企業概要、2019年～2022年までの赤羽ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な赤羽ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別赤羽ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの赤羽ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での赤羽ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および赤羽ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、赤羽ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 赤羽ワクチンの概要
– 種類別分析（2017年vs2021年vs2028年）：生ワクチン、不活化ワクチン
– 用途別分析（2017年vs2021年vs2028年）：牛、水牛、その他
– 世界の赤羽ワクチン市場規模・予測
– 世界の赤羽ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– CAVAC、Green Cross Veterinary Products、KAKETSUKEN、Kyoritsu Seiyaku Corporation、Kyoto Biken Laboratories、Nisseiken
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：生ワクチン、不活化ワクチン
・用途別分析2017年-2028年：牛、水牛、その他
・赤羽ワクチンの北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・赤羽ワクチンのヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・赤羽ワクチンのアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・赤羽ワクチンの南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・赤羽ワクチンの中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Akabane Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Akabane Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Akabane Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cattle
1.3.3 Buffalo
1.3.4 Other
1.4 Global Akabane Vaccines Market Size & Forecast
1.4.1 Global Akabane Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Akabane Vaccines Sales in Volume (2017-2028)
1.4.3 Global Akabane Vaccines Price (2017-2028)
1.5 Global Akabane Vaccines Production Capacity Analysis
1.5.1 Global Akabane Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Akabane Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Akabane Vaccines Market Drivers
1.6.2 Akabane Vaccines Market Restraints
1.6.3 Akabane Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 CAVAC
2.1.1 CAVAC Details
2.1.2 CAVAC Major Business
2.1.3 CAVAC Akabane Vaccines Product and Services
2.1.4 CAVAC Akabane Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Green Cross Veterinary Products
2.2.1 Green Cross Veterinary Products Details
2.2.2 Green Cross Veterinary Products Major Business
2.2.3 Green Cross Veterinary Products Akabane Vaccines Product and Services
2.2.4 Green Cross Veterinary Products Akabane Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 KAKETSUKEN
2.3.1 KAKETSUKEN Details
2.3.2 KAKETSUKEN Major Business
2.3.3 KAKETSUKEN Akabane Vaccines Product and Services
2.3.4 KAKETSUKEN Akabane Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kyoritsu Seiyaku Corporation
2.4.1 Kyoritsu Seiyaku Corporation Details
2.4.2 Kyoritsu Seiyaku Corporation Major Business
2.4.3 Kyoritsu Seiyaku Corporation Akabane Vaccines Product and Services
2.4.4 Kyoritsu Seiyaku Corporation Akabane Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Kyoto Biken Laboratories
2.5.1 Kyoto Biken Laboratories Details
2.5.2 Kyoto Biken Laboratories Major Business
2.5.3 Kyoto Biken Laboratories Akabane Vaccines Product and Services
2.5.4 Kyoto Biken Laboratories Akabane Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Nisseiken
2.6.1 Nisseiken Details
2.6.2 Nisseiken Major Business
2.6.3 Nisseiken Akabane Vaccines Product and Services
2.6.4 Nisseiken Akabane Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Akabane Vaccines Breakdown Data by Manufacturer
3.1 Global Akabane Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Akabane Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Akabane Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Akabane Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Akabane Vaccines Manufacturer Market Share in 2021
3.5 Global Akabane Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Akabane Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Akabane Vaccines Market Size by Region
4.1.1 Global Akabane Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Akabane Vaccines Revenue by Region (2017-2028)
4.2 North America Akabane Vaccines Revenue (2017-2028)
4.3 Europe Akabane Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Akabane Vaccines Revenue (2017-2028)
4.5 South America Akabane Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Akabane Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Akabane Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Akabane Vaccines Revenue by Type (2017-2028)
5.3 Global Akabane Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Akabane Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Akabane Vaccines Revenue by Application (2017-2028)
6.3 Global Akabane Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Akabane Vaccines Sales by Type (2017-2028)
7.2 North America Akabane Vaccines Sales by Application (2017-2028)
7.3 North America Akabane Vaccines Market Size by Country
7.3.1 North America Akabane Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Akabane Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Akabane Vaccines Sales by Type (2017-2028)
8.2 Europe Akabane Vaccines Sales by Application (2017-2028)
8.3 Europe Akabane Vaccines Market Size by Country
8.3.1 Europe Akabane Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Akabane Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Akabane Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Akabane Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Akabane Vaccines Market Size by Region
9.3.1 Asia-Pacific Akabane Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Akabane Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Akabane Vaccines Sales by Type (2017-2028)
10.2 South America Akabane Vaccines Sales by Application (2017-2028)
10.3 South America Akabane Vaccines Market Size by Country
10.3.1 South America Akabane Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Akabane Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Akabane Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Akabane Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Akabane Vaccines Market Size by Country
11.3.1 Middle East & Africa Akabane Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Akabane Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Akabane Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Akabane Vaccines
12.3 Akabane Vaccines Production Process
12.4 Akabane Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Akabane Vaccines Typical Distributors
13.3 Akabane Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Akabane Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Akabane Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CAVAC Basic Information, Manufacturing Base and Competitors
Table 4. CAVAC Major Business
Table 5. CAVAC Akabane Vaccines Product and Services
Table 6. CAVAC Akabane Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Green Cross Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 8. Green Cross Veterinary Products Major Business
Table 9. Green Cross Veterinary Products Akabane Vaccines Product and Services
Table 10. Green Cross Veterinary Products Akabane Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. KAKETSUKEN Basic Information, Manufacturing Base and Competitors
Table 12. KAKETSUKEN Major Business
Table 13. KAKETSUKEN Akabane Vaccines Product and Services
Table 14. KAKETSUKEN Akabane Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Kyoritsu Seiyaku Corporation Basic Information, Manufacturing Base and Competitors
Table 16. Kyoritsu Seiyaku Corporation Major Business
Table 17. Kyoritsu Seiyaku Corporation Akabane Vaccines Product and Services
Table 18. Kyoritsu Seiyaku Corporation Akabane Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Kyoto Biken Laboratories Major Business
Table 21. Kyoto Biken Laboratories Akabane Vaccines Product and Services
Table 22. Kyoto Biken Laboratories Akabane Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 24. Nisseiken Major Business
Table 25. Nisseiken Akabane Vaccines Product and Services
Table 26. Nisseiken Akabane Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Akabane Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Akabane Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Akabane Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Akabane Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Akabane Vaccines Production Site of Key Manufacturer
Table 32. Akabane Vaccines New Entrant and Capacity Expansion Plans
Table 33. Akabane Vaccines Mergers & Acquisitions in the Past Five Years
Table 34. Global Akabane Vaccines Sales by Region (2017-2022) & (K Units)
Table 35. Global Akabane Vaccines Sales by Region (2023-2028) & (K Units)
Table 36. Global Akabane Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Akabane Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Akabane Vaccines Sales by Type (2017-2022) & (K Units)
Table 39. Global Akabane Vaccines Sales by Type (2023-2028) & (K Units)
Table 40. Global Akabane Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Akabane Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Akabane Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 43. Global Akabane Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 44. Global Akabane Vaccines Sales by Application (2017-2022) & (K Units)
Table 45. Global Akabane Vaccines Sales by Application (2023-2028) & (K Units)
Table 46. Global Akabane Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Akabane Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Akabane Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Akabane Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 50. North America Akabane Vaccines Sales by Country (2017-2022) & (K Units)
Table 51. North America Akabane Vaccines Sales by Country (2023-2028) & (K Units)
Table 52. North America Akabane Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Akabane Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Akabane Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. North America Akabane Vaccines Sales by Type (2023-2028) & (K Units)
Table 56. North America Akabane Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. North America Akabane Vaccines Sales by Application (2023-2028) & (K Units)
Table 58. Europe Akabane Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. Europe Akabane Vaccines Sales by Country (2023-2028) & (K Units)
Table 60. Europe Akabane Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Akabane Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Akabane Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Europe Akabane Vaccines Sales by Type (2023-2028) & (K Units)
Table 64. Europe Akabane Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. Europe Akabane Vaccines Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Akabane Vaccines Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Akabane Vaccines Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Akabane Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Akabane Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Akabane Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Akabane Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Akabane Vaccines Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Akabane Vaccines Sales by Application (2023-2028) & (K Units)
Table 74. South America Akabane Vaccines Sales by Country (2017-2022) & (K Units)
Table 75. South America Akabane Vaccines Sales by Country (2023-2028) & (K Units)
Table 76. South America Akabane Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Akabane Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Akabane Vaccines Sales by Type (2017-2022) & (K Units)
Table 79. South America Akabane Vaccines Sales by Type (2023-2028) & (K Units)
Table 80. South America Akabane Vaccines Sales by Application (2017-2022) & (K Units)
Table 81. South America Akabane Vaccines Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Akabane Vaccines Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Akabane Vaccines Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Akabane Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Akabane Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Akabane Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Akabane Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Akabane Vaccines Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Akabane Vaccines Sales by Application (2023-2028) & (K Units)
Table 90. Akabane Vaccines Raw Material
Table 91. Key Manufacturers of Akabane Vaccines Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Akabane Vaccines Typical Distributors
Table 95. Akabane Vaccines Typical Customers
List of Figures
Figure 1. Akabane Vaccines Picture
Figure 2. Global Akabane Vaccines Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global Akabane Vaccines Revenue Market Share by Application in 2021
Figure 6. Cattle
Figure 7. Buffalo
Figure 8. Other
Figure 9. Global Akabane Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Akabane Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Akabane Vaccines Sales (2017-2028) & (K Units)
Figure 12. Global Akabane Vaccines Price (2017-2028) & (USD/Unit)
Figure 13. Global Akabane Vaccines Production Capacity (2017-2028) & (K Units)
Figure 14. Global Akabane Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Akabane Vaccines Market Drivers
Figure 16. Akabane Vaccines Market Restraints
Figure 17. Akabane Vaccines Market Trends
Figure 18. Global Akabane Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global Akabane Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. Akabane Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Akabane Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Akabane Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Akabane Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global Akabane Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America Akabane Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe Akabane Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Akabane Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America Akabane Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Akabane Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global Akabane Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Akabane Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Akabane Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Akabane Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global Akabane Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global Akabane Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Akabane Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America Akabane Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America Akabane Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America Akabane Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Akabane Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe Akabane Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Akabane Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe Akabane Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Akabane Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Akabane Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Akabane Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Akabane Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Akabane Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America Akabane Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America Akabane Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America Akabane Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Akabane Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Akabane Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Akabane Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Akabane Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Akabane Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Akabane Vaccines in 2021
Figure 77. Manufacturing Process Analysis of Akabane Vaccines
Figure 78. Akabane Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • アフリカ馬疫ワクチンの世界市場2022：生ワクチン、不活化ワクチン
  • 青眼病ワクチンの世界市場2022：生ワクチン、不活化ワクチン
  • 豚流行性下痢ワクチンの世界市場2022：生ワクチン、不活化ワクチン
  • 豚インフルエンザワクチンの世界市場2022：生ワクチン、不活化ワクチン
  • 鶏用ワクチンの世界市場2022：生ワクチン、不活化ワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3739 )"赤羽ワクチンの世界市場2022：生ワクチン、不活化ワクチン" (英文：Global Akabane Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。